Summary Fatty liver is commonly associated with alcohol or metabolic syndrome. We aimed to examine the longitudinal aspects of fatty liver, and clarify the independent predictors for the development or regression of fatty liver. In the present study, the clinical features of 1578 Japanese adults (1208 men and 370 women; 35 to 69 years of age) who visited our center both in 2000 and 2007-2008 were recorded and compared, including liver status diagnosed by ultrasonography. Of the 1578 participants, 217 (13.8%) showed fatty liver development, and 74 (4.7%) showed fatty liver regression. Logistic regression analysis revealed that body mass index and percentage body fat were strongly associated with the development or regression of fatty liver. Metabolic syndrome-related disorders such as serum levels of total cholesterol, triglyceride, uric acid, and fasting blood glucose were also associated with clinical course to some degree. However, the history of alcohol intake, the presence of metabolic syndrome, blood pressure, and habitual physical exercise were not independent predictors for the development or regression of fatty liver. Our present data suggest that control of body weight in men and the percentage body fat in women are particularly important for the prevention or treatment of fatty liver.
Introduction
Fatty liver (steatosis) is defined as an accumulation of fat, mainly triglyceride, in liver cells. This disease is commonly associated with alcohol or metabolic syndrome (diabetes mellitus, hypertension, and dyslipidemia) [1] . In particular, non-alcoholic fatty liver diseases (NAFLD) are recognized as the hepatic manifestation of metabolic syndrome and the prevalence of this entity is increasing in many countries [2] [3] [4] . In Japan, Kojima et al. [5] reported that the prevalence of fatty liver rose gradually from 12.6% in 1989 to 30.3% in 1998; this was mainly due to an increase in body mass index (BMI). Hamaguchi et al. [6] reported that metabolic syndrome was a risk factor for the development of NAFLD, and conversely, Fan et al. [4] suggested that the presence of NAFLD might predict the development of metabolic syndrome. Lifestyle changes, including weight loss and physical exercise, have been shown to improve the clinical course in NAFLD [3, 7] .
In our previous study, we examined the frequency of fatty liver diagnosed by ultrasonography (USG) in 3432 Japanese adults who visited Health Service Center, Mitsubishi Heavy Industries, Ltd., Nagasaki Shipyard and Machinery Works Hospital, Nagasaki, Japan for a thorough medical examination between January and December 2000 and found that BMI was the most independent predictor for the presence of fatty liver in both sexes [8] . We further reported that percentage body fat was a useful index to assess the etiology of fatty liver in non-alcoholic and non-overweight participants, particularly women.
In the present study, we aimed to examine the longitudinal aspects of fatty liver in each participant who visited the same health checkup center. We also clarified the independent predictors for the development or regression of fatty liver in non-alcoholic participants.
Materials and Methods

Study participants
Of the 3432 Japanese participants who visited the Health Service Center, Mitsubishi Heavy Industries, Ltd., Nagasaki Shipyard and Machinery Works Hospital, Nagasaki, Japan for a thorough medical examination between January and December 2000 (in 2000) [8] , 1589 also visited the same Center between April 2007 and March 2008 (in 2007-2008) . The medical examination was performed for subjects who visited the hospital voluntarily (most of them were employees or their families) to promote public health through early detection of chronic diseases. Of these 1589 participants, we excluded 6 participants who turned positive for anti-hepatitis C virus antibody and 5 participants who did not undergo USG in 2007-2008 from the present study. Therefore, the total number of study subjects was 1578 (1208 men and 370 women; mean age, 54.0 ± 4.7 years; range, 35 to 69 years). This study was performed according to the principles of the Declaration of Helsinki. The study protocol was approved by the Ethical Committees of Siebold University of Nagasaki and Mitsubishi Heavy Industries, Ltd., Nagasaki Shipyard and Machinery Works Hospital. Informed consent was obtained from all participants.
Data collection and measurements
The medical examination was performed between 8:00-11:00 am after overnight fasting. The information obtained from the medical records for the present study included sex, age, height, body weight, history of alcohol intake, present physical exercise habit, history of medical treatment for hypertension, dyslipidemia, and/or diabetes mellitus, systolic blood pressure (SBP), diastolic blood pressure (DBP), serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), γ-glutamyl transpeptidase (GGTP), total choresterol (T.Chol.), triglyceride (TG), uric acid (UA), fasting blood glucose (FBG), percentage body fat (% fat volume), and liver status by USG.
The history of alcohol intake, present physical exercise habit and history of medical treatment for hypertension, dyslipidemia and/or diabetes mellitus were determined by questionnaire. The history of alcohol intake was divided into three groups as follows: never drinker, heavy drinker (at least 70 g/day of alcohol intake more than 5 times per week), and moderate drinker (neither never drinker nor heavy drinker). Regarding the present physical exercise habit, participants marked "yes" if they had a habit of physical exercise such as jogging, walking, or playing tennis, golf, or badminton. Regarding the history of medical treatment for hypertension, dyslipidemia and/or diabetes mellitus, participants marked "yes" if they had been receiving medical treatment for such diseases.
The body mass index (BMI) was calculated as body weight (kg) divided by height (m 2 ). Overweight was defined as a BMI of ≥25 kg/m 2 [9] . The percentage body fat measurement was performed using a bipedal bioimpedance instrument (Body Fat Analyzer TBF-202; Tanita, Tokyo, Japan). Obesity was defined for Japanese adults as ≥25% body fat for men and ≥30% body fat for women [8] .
Abdominal ultrasonography was performed by clinical hepatogastroenterologists or trained technicians without knowledge of the anthropometric and laboratory data. When USG was performed by a trained technician, one hepatogastroenterologist reviewed the stored ultrasonographic images and made the final diagnosis. The diagnosis of fatty liver by USG (Aloka Pro Sound SSD-4000; Aloka, Tokyo, Japan) was based on the findings of "bright liver" (increased echogenicity) with "liver-kidney contrast" (increased echo level of the liver compared with the right kidney). "Vascular blurring" (blurring of the hepatic vein) and "deep attenuation" (attenuation of the echo level in the deep region of the liver) were also seen in many cases, but their absence did not exclude the diagnosis of fatty liver.
The standard Japanese criteria for the diagnosis of metabolic syndrome are as follows. The presence of visceral fat accumulation (defined as waist circumference ≥85 cm for men and ≥90 cm for women) is an indispensable factor, with any two or more of the following criteria: (1) a high serum level of triglyceride (≥150 mg/dL or ≥1.7 mmol/L) and/or low serum level of high-density lipoprotein (HDL) cholesterol (<40 mg/dL or <1.03 mmol/L) or receiving specific treatment for these abnormalities; (2) high blood pressure (SBP ≥130 mmHg and/or DBP ≥85 mmHg) or receiving specific treatment for hypertension; (3) high FBG concentration (≥110 mg/dL or ≥6.11 mmol/L) or receiving specific treatment for glucose abnormality [10] . Because waist circumference and serum level of HDL cholesterol were not available in our study subjects, we substituted a BMI ≥25 kg/m 2 for waist circumference, and omitted the HDL cholesterol. Therefore, we defined a "tentative metabolic syndrome" as follows: BMI ≥25 kg/m 2 plus at least two of the following three factors: (1) a high serum level of triglyceride (≥150 mg/dL) or receiving specific treatment for triglyceride abnormality; (2) high blood pressure (SBP ≥130 mmHg and/or DBP ≥85 mmHg) or receiving specific treatment for hypertension; (3) high FBG concentration (≥110 mg/dL) or receiving specific treatment for glucose abnormality. Serum level of low-density lipoprotein (LDL) cholesterol was also unavailable in our study population.
Comparison of data between 2000 and 2007-2008
In 
Statistical analysis
Data were expressed as mean ± standard deviation (SD) or median (range). Differences between groups were examined for statistical significance using the two-tailed Mann-Whitney U test, Wilcoxon signed-rank test, chi-square test, or Fisher's exact probability test. Multivariate analysis for the development or regression of fatty liver was performed for variables that were significant in univariate analyses using logistic regression analysis. Correlations were examined by linear regression analysis using the coefficient of correlation. All data analyses were performed using SPSS statistical package, version 16.0J (SPSS, Inc., Chicago, IL) on a computer with a Windows operating system. A p-value less than 0.05 was considered statistically significant.
Results
Clinical and laboratory features of participants in 2007-2008
The participants' age in 2007-2008 was significantly higher in men (54.4 ± 4.7 years; range, 41 to 69 years) than in women (52.7 ± 4.6 years; range, 35 to 65 years) (p<0.001). The number and frequency of participants for each clinical and laboratory feature are shown in Table 1 . Of the 1578 participants, fatty liver was diagnosed by USG in 501 (31.7%). Of the 370 women in the study, 247 (66.8%) were obese (≥30% fat volume).
Fatty liver was more frequently seen in men and overweight as well as obese participants. Systolic and diastolic blood pressure, serum levels of AST, ALT, GGTP, T.Chol, TG, UA, and FBG were higher in participants with fatty liver than in those with non-fatty liver. Participants who have "tentative metabolic syndrome" and who had been receiving treatment for hypertension, dyslipidemia and/or diabetes mellitus were more frequently found in the fatty liver group. In contrast, there were no significant differences in age and the proportion of alcohol drinker between the fatty liver and non-fatty liver groups of participants. Physical exercise habit was more common in the non-fatty liver group ( Table 2) . 
Clinical and laboratory features of participants who were classified as non-drinkers
To determine the clinical and laboratory features of fatty liver and non-fatty liver in non-alcoholic participants, the data from 346 participants who were classified as nondrinkers [never drinker or occasional drinker (1-4 times per week) in 2000 [8] and never drinker in [2007] [2008] were analyzed. Of these 346 participants, 102 had fatty liver in 2007-2008 and fatty liver was more frequently seen in men, overweight, and obese participants. Systolic and diastolic blood pressures, serum levels of AST, ALT, GGTP, TG, UA, and FBG were higher in participants with fatty liver than in those without fatty liver. Participants who had "tentative metabolic syndrome" and who had been receiving treatment for hypertension, dyslipidemia and/or diabetes mellitus were more frequently found in the fatty liver group. In contrast, there were no significant differences in age and serum level of T.Chol. between participants with and without fatty liver. Physical exercise habit was more common in the non-fatty liver group (Table 4 (Table 6 ). (Table 8) . (Table 9) .
In participants who were classified as non-drinkers, positive % change in BMI and high percentage body fat in 2000 were independent predictors for the development of fatty liver in 2007-2008 in men and women, respectively. Negative % change in BMI and decrease in FBG were independent predictors for the regression of fatty liver in 2007-2008 in men (Table 9 ).
Discussion
The relation between fatty liver and metabolic syndromerelated disorders such as obesity is well known, but data from longitudinal observation (with sufficient duration) of individuals in a large population are hitherto sparse. Kojima et al. [5] reported that 5088 (14.3%) of 35519 participants developed fatty liver, and that fatty liver resolved in 1248 (3.5%) of those participants during the follow-up period from 1989 to 2000. They further reported that BMI, as well as the relative change in BMI in each individual, was related to the onset of fatty liver, followed by serum levels of TG and FBG in both sexes, and that alcohol intake did not have any relation to the onset of fatty liver, in contrast with the data from the Dionysos study [11] . Our present results were partly in line with these findings, because 217 (13.8%) of 1578 participants developed fatty liver, which resolved in 74 (4.7%) participants, and the logistic regression analysis revealed that alcohol consumption was not a predictor for the development of fatty liver as previously reported [8, 12] . However, in contrast with the results by Kojima et al. [5] , not BMI but high percentage body fat in 2000 and increased % change in percentage body fat during the follow-up period in each participant were independent predictors for the development of fatty liver in both sexes in the present study. Eguchi et al. [13] reported that hepatic fat infiltration in NAFLD might be influenced by visceral fat accumulation regardless of BMI. Imamura et al. [14] also reported that altered body composition, particularly increased percentage body fat without an increase in BMI, was strongly associated with the increasing prevalence of fatty liver. Indeed, the change in BMI between 2000 and 2007-2008 was constantly associated with the development and regression of fatty liver in men regardless of the history of alcohol intake in the present study. In contrast, in women, a high percentage body fat in 2000 was associated with the development of fatty liver in 2007-2008 regardless of alcohol consumption. The BMI is chosen as a measure of overall adiposity and elevated percentage body fat with normal BMI can be presumed to reflect central body fat distribution [8] . Lonardo et al. [12] reported that women with fatty liver had a more central fat distribution, which reflects visceral fat, than women without fatty liver, and concluded that this central-type body fat distribution predicted fatty liver only in women. Our results support these data and sex differences in the pathogenesis and treatment of fatty liver, particularly NAFLD, should be further determined.
Metabolic syndrome-related disorders with abnormal serum levels of T.Chol., TG, UA, and FBG were associated with the development or regression of fatty liver in men and women with or without alcohol intake in the present study. Refer to the legends of Table 1 and 5 for abbreviations. However, the presence of "tentative metabolic syndrome" was not an independent predictor for the development or regression of fatty liver. Hamaguchi et al. [6] studied 4401 Japanese adults, and 308 (7.0%) of those participants developed fatty liver, which resolved in 113 (2.6%) participants during the mean follow-up period of 414 days. In their study population, the presence of metabolic syndrome at baseline was one of the independent predictors for the development and regression of fatty liver in both sexes. One possible explanation for these discrepant results may be the difference in diagnostic criteria of the metabolic syndromes.
In contrast with the ATP III criteria [15] , which were adopted by Hamaguchi et al. [6] , the Japanese criteria for the diagnosis of metabolic syndrome adopted in the present study defined the presence of central obesity (waist circumference) as a pre-requisite and indispensable factor [10] . Because waist circumference was not available in our study subjects, we followed the method used by Hamaguchi et al. [6] and substituted a BMI ≥25 kg/m 2 instead of waist circumference. However, if the participants were not overweight as judged by BMI, they failed to be included in the group of subjects with "tentative metabolic syndrome". Since International Diabetes Federation also proposed central obesity (waist circumference) as an indispensable factor for the diagnosis of metabolic syndrome [16] , detailed evaluation of metabolic syndrome including the measurement of waist circumference should be performed in the near future.
Blood pressures, both SBP and DBP, and physical activity were not independent predictors for the development or regression of fatty liver in our study population. Donati et al. [17] reported that insulin resistance, a factor independently associated with fatty liver, was predicted by the presence of arterial hypertension in non-obese, non-diabetic, non-heavy alcohol drinking patients with arterial hypertensive and normal liver enzymes. Akahoshi et al. [18] also reported that non-obese male participants with fatty liver had the highest odds ratio for hypertension. Unfortunately, we did not perform such analysis, and the discrepancy between these results and ours is unclear. The association between arterial hypertension or physical activity and fatty liver remains uncertain and requires further investigation. Physical activity may also reduce the associated risk factors and prevent the progression of fatty liver, especially NAFLD, but the independent contribution on variations in liver fat is so far unknown [19, 20] . In our study, there was a limitation because self-reported information regarding habitual physical activity, as well as alcohol consumption, can lead to underor over-reporting. A direct interview by trained medical staff should have been performed to get accurate information from individuals.
In conclusion, BMI and percentage body fat were strongly associated with the development or regression of fatty liver regardless of the history of alcohol intake in the present study. Metabolic syndrome-related disorders such as serum levels of T.Chol., TG, UA, and FBG were also associated with such clinical features in some degree. Although most patients with NAFLD have a benign clinical course [21] , the presence of multiple metabolic disorders can be associated with potentially progressive and severe liver diseases such as non-alcoholic steatohepatitis [22, 23] . Our present data suggest that control of body weight in men and the percentage body fat in women are particularly important for the prevention or treatment of fatty liver, followed by the control of dyslipidemia, hyperuricemia, and hyperglycemia. 
